WeVote

Bill

Bill

SB 682

Alzheimer's Disease and Related Disorders Commission; extends sunset provision.

2026 Regular Session Introduced by Christie Craig and 8 co-sponsors

Virginia extends the Alzheimer's Disease and Related Disorders Commission's operating authority to continue coordinating state dementia prevention, research, and care initiatives.

Acts of Assembly Chapter text (CHAP0141)
0
WeVote Research Nonpartisan
Bill Summary · SB 682

Legislative bill overview

SB 682 extends the expiration date of Virginia's Alzheimer's Disease and Related Disorders Commission, allowing it to continue operating beyond its scheduled sunset date. The bill maintains the commission's authority to coordinate state efforts on Alzheimer's disease prevention, care, and research initiatives.

Why is this important

Alzheimer's disease affects approximately 120,000 Virginians and represents a growing public health challenge as the population ages. Commission continuity ensures ongoing coordination of state resources, research funding, and care standards for one of the nation's fastest-growing neurological conditions.

Potential points of contention

  • Fiscal implications: The fiscal impact statement indicates ongoing state expenditures; costs of maintaining the commission versus budget constraints may generate debate
  • Effectiveness assessment: Questions may arise about whether the commission has demonstrated measurable results justifying its continuation
  • Scope of authority: Disagreement over whether the commission's mandate adequately addresses emerging treatment options and care delivery models

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.